Bottom line
FTWCX vs SCHA: the short answer
FTWCX (FullerThaler Behavioral Small-Mid Core Equity Fund) and SCHA (Schwab U.S. Small-Cap ETF) are both mutual funds.
But SCHA is far broader, holding 1,708 positions to 55 for FTWCX, so beyond the top names it adds exposure FTWCX doesn't have.
SCHA is cheaper at 0.03% vs 1.82% — a difference of $179 a year per $10,000 invested.
Over one year, SCHA returned +11.1% vs −0.9% for FTWCX (reporting dates differ).
Updated Nov 19, 2026
FTWCX vs SCHA side by side
| FTWCX | SCHA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | Schwab |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 1.82% | 0.03% |
| Annual cost per $10k | $182 | $3 |
| 10-yr cost on $10k (prospectus) | $2,167 | $39 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | — |
| 1-yr return | −0.9% | +11.1% |
| 5-yr return (annualized) | — | +8.0% |
| 10-yr return (annualized) | — | +8.0% |
| Best quarter | +28.7% | +30.8% |
| Worst quarter | −31.1% | −31.6% |
| Net assets (fund) | $522.6M | $22.8B |
| Number of holdings | 55 | 1,708 |
| Portfolio turnover | 25% | 11% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
FTWCX and SCHA share none of their top holdings.
FTWCX top 10
- Teradyne Inc — 3.78%
- Devon Energy Corp — 3.04%
- Advanced Energy Industries Inc — 2.73%
- Comfort Systems USA Inc — 2.73%
- N/a — 2.68%
- Matson Inc — 2.68%
- Neurocrine Biosciences Inc — 2.52%
- Owens Corning — 2.50%
- Masco Corp — 2.49%
- Coca-cola Consolidated Inc — 2.36%
SCHA top 10
- Sandisk Corp/DE — 5.28%
- State Street Institutional US Government Money Market Fund — 1.65%
- Lumentum Holdings Inc — 1.29%
- Revolution Medicines Inc — 0.65%
- Sterling Infrastructure Inc — 0.56%
- ATI Inc — 0.50%
- MACOM Technology Solutions Holdings Inc — 0.50%
- Nextpower Inc — 0.49%
- MKS Inc — 0.46%
- Coeur Mining Inc — 0.42%
FAQ
What is the difference between FTWCX and SCHA?
Which is cheaper, FTWCX or SCHA?
Should I own both FTWCX and SCHA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.